{"denoms":[{"counts":[{"groupId":"BG000","value":"82"}],"units":"Participants"}],"groups":[{"description":"lenalidomide 15 mg/day, for 21 days with 7 days rest (28 day cycle) with or without dexamethasone 20 mg daily (10 mg twice daily) on Days 1-4, 9-12, and 17-20 of every other 28-day cycle.\n\ndexamethasone: dexamethasone 20 mg daily (10 mg twice daily) on Days 1-4, 9-12, and 17-20 of every other 28-day cycle.\n\nlenalidomide: 15 mg/day, for 21 days with 7 days rest (28 day cycle) with or without dexamethasone","id":"BG000","title":"Revlimid"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"58"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"24"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"53"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Gender","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}],"title":"on dialysis"},{"measurements":[{"groupId":"BG000","value":"75"}],"title":"Not on dialysis"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Dialysis y/n","unitOfMeasure":"Participants"}]}